1、 陈小龙. COX-2抑制剂对食管鳞癌患者调节性T细胞及细胞免疫的影响[D]. 川北医学院,2016. 陈小龙. COX-2抑制剂对食管鳞癌患者调节性T细胞及细胞免疫的影响[D]. 川北医学院,2016.
2、 蔺茹君,李思源,肖智伟,等. 塞来昔布抑制食管癌细胞系ECa109增殖[J]. 基础医学与临床,2019,39(1):88-89. 蔺茹君,李思源,肖智伟,等. 塞来昔布抑制食管癌细胞系ECa109增殖[J]. 基础医学与临床,2019,39(1):88-89.
3、 张康. 塞来昔布对食管癌Eca-109细胞增殖及凋亡的影响[D]. 大理学院,2013. 张康. 塞来昔布对食管癌Eca-109细胞增殖及凋亡的影响[D]. 大理学院,2013.
4、 李红涛,王晓东.塞来昔布对人食管癌细胞株Eca-109增殖和凋亡的影响[J]. 锦州医学院学报,2006(6):32-35. 李红涛,王晓东.塞来昔布对人食管癌细胞株Eca-109增殖和凋亡的影响[J]. 锦州医学院学报,2006(6):32-35.
5、 SUI W, ZHANG Y, WANG Z, et al. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H22 murinehepatocarcinoma model[J]. Oncol Rep, 2014, 31(5):2252. SUI W, ZHANG Y, WANG Z, et al. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H22 murinehepatocarcinoma model[J]. Oncol Rep, 2014, 31(5):2252.
6、 LIU J F,ZHU G J,GLYN G,et al. NS-398 induces apoptesis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygonase-2[J]. Cancer Inverst, 2009,27(1):17-23. LIU J F,ZHU G J,GLYN G,et al. NS-398 induces apoptesis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygonase-2[J]. Cancer Inverst, 2009,27(1):17-23.
7、 GIROSCH S. MAIER T J, SCHIFFMANN S, et al. cyclooxygenase-2(COX-2)-independent anticarcinogenic effects of selective cox-2 inhibitors[J]. J Natl Caneer Inst, 2006, 98(11): 736-747. GIROSCH S. MAIER T J, SCHIFFMANN S, et al. cyclooxygenase-2(COX-2)-independent anticarcinogenic effects of selective cox-2 inhibitors[J]. J Natl Caneer Inst, 2006, 98(11): 736-747.
8、 IZZO J G, AJANI J A. Thinking in and out of the box when it comes to gastric cancer and cyclooxygenase-2[J]. J Clin Oncol,2007,25(31):4865-4867. IZZO J G, AJANI J A. Thinking in and out of the box when it comes to gastric cancer and cyclooxygenase-2[J]. J Clin Oncol,2007,25(31):4865-4867.
9、 吕歆.COX-2、VEGF及miRNA表达水平与食管鳞状细胞癌患者的临床疗效及预后的关系[J]. 实用癌症杂志,2019,34(3):403-406. 吕歆.COX-2、VEGF及miRNA表达水平与食管鳞状细胞癌患者的临床疗效及预后的关系[J]. 实用癌症杂志,2019,34(3):403-406.
10、 胡真真. COX-2、Livin、Ki-67在鼻腔鼻窦鳞状细胞癌中的表达及临床意义[D]. 郑州大学,2019. 胡真真. COX-2、Livin、Ki-67在鼻腔鼻窦鳞状细胞癌中的表达及临床意义[D]. 郑州大学,2019.
11、 JAWANJAL P, SALHAN S, DHAWAN I,et al. Augmented activity of Cyclooxygenase-2 in Tissue and Serum of Patients With Cervical Cancer[J]. J Clin Lab Anal,2016,30(6):1198-1207. JAWANJAL P, SALHAN S, DHAWAN I,et al. Augmented activity of Cyclooxygenase-2 in Tissue and Serum of Patients With Cervical Cancer[J]. J Clin Lab Anal,2016,30(6):1198-1207.
12、 MARUTHA M A,CHEAH P L,KOH C C,et al. Cyclooxygenase-2(cox2)expression in adenocarcinoma surpasses that of squamous cell carcinoma in the uterine cervix[J]. Malays J Pathol,2017,39(3):251-255. MARUTHA M A,CHEAH P L,KOH C C,et al. Cyclooxygenase-2(cox2)expression in adenocarcinoma surpasses that of squamous cell carcinoma in the uterine cervix[J]. Malays J Pathol,2017,39(3):251-255.
13、 蒋海涛,徐颖,王兴兰,等. β-catenin、COX-2、15-PGDH在结直肠癌组织中的表达及意义[J]. 中国老年学杂志,2019,39(13):3127-3130. 蒋海涛,徐颖,王兴兰,等. β-catenin、COX-2、15-PGDH在结直肠癌组织中的表达及意义[J]. 中国老年学杂志,2019,39(13):3127-3130.
14、 孙亚丽,陈琳.非小细胞肺癌患者EB病毒感染与COX-2和P-糖蛋白的相关性[J]. 临床与病理杂志,2019(7):1428-1434. 孙亚丽,陈琳.非小细胞肺癌患者EB病毒感染与COX-2和P-糖蛋白的相关性[J]. 临床与病理杂志,2019(7):1428-1434.
15、 林明飞,陆裕富,曽凡.老年甲状腺癌组织中MMP-2、TIMP-2及COX-2的表达及临床意义[J]. 华中科技大学学报(医学版),2019,48(4):466-469. 林明飞,陆裕富,曽凡.老年甲状腺癌组织中MMP-2、TIMP-2及COX-2的表达及临床意义[J]. 华中科技大学学报(医学版),2019,48(4):466-469.
16、 YUSUP G,AKUTSU Y,MUTALLIP M,et al. A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma[J]. Int J Oncol, 2014,44(4):1146-1152. YUSUP G,AKUTSU Y,MUTALLIP M,et al. A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma[J]. Int J Oncol, 2014,44(4):1146-1152.
17、 FERLAY M, COLOMBET I, SOERJOMATARAM C, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer,2019,144(8):1941-1953. FERLAY M, COLOMBET I, SOERJOMATARAM C, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer,2019,144(8):1941-1953.
18、 郭康,周脉耕,石娅娅,等. 2006-2012年中国人群食管癌死亡趋势分析[J]. 现代预防医学,2015,42(7):1153-1156. 郭康,周脉耕,石娅娅,等. 2006-2012年中国人群食管癌死亡趋势分析[J]. 现代预防医学,2015,42(7):1153-1156.
19、 吴伟江,宿宝贵. 塞来昔布联合阿霉素促胃癌细胞凋亡作用的探讨[J]. 中国临床解剖学杂志,2006,24(2):194-197. 吴伟江,宿宝贵. 塞来昔布联合阿霉素促胃癌细胞凋亡作用的探讨[J]. 中国临床解剖学杂志,2006,24(2):194-197.
20、 汪勤,孟刚,鲍扬漪,等. 1,25二羟维生素D_3联合塞莱昔布对乳腺癌细胞株Hs578T的增殖抑制及凋亡诱导作用[J]. 安徽医科大学学报,2009,44(2):244-248. 汪勤,孟刚,鲍扬漪,等. 1,25二羟维生素D_3联合塞莱昔布对乳腺癌细胞株Hs578T的增殖抑制及凋亡诱导作用[J]. 安徽医科大学学报,2009,44(2):244-248.
21、 洪源.塞来昔布通过L1CAM下调Stat3/NF-κB的表达抑制胰腺癌细胞Panc-1和Bxpc-3的增殖和转移[D]. 南华大学,2016. 洪源.塞来昔布通过L1CAM下调Stat3/NF-κB的表达抑制胰腺癌细胞Panc-1和Bxpc-3的增殖和转移[D]. 南华大学,2016.
22、 詹磊,程良斌,蔡岳.塞来昔布抑制COX-2和PD-1发挥抗肝癌作用[J]. 中国免疫学杂志,2018,34(4):595-599. 詹磊,程良斌,蔡岳.塞来昔布抑制COX-2和PD-1发挥抗肝癌作用[J]. 中国免疫学杂志,2018,34(4):595-599.
23、 TSUTSUMI S,NAMBA T.Celecoxib upregulates endoplasmic reticulun chapernoes that inhibit celecoxib induced apoptosis in human gastric cells[J]. Oncogene, 2006, 25(7):1018-1029. TSUTSUMI S,NAMBA T.Celecoxib upregulates endoplasmic reticulun chapernoes that inhibit celecoxib induced apoptosis in human gastric cells[J]. Oncogene, 2006, 25(7):1018-1029.
